Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes 7thSpace Interactive (press release) Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes. Lysophosphatidic acid (LPA) is a bioactive phospholipid with a potentially causative role in neurotrauma. Blocking LPA signaling with the LPA-directed monoclonal antibody ... |
